Neoplasms

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Gland and Hormone Related Diseases

All Conditions

Symptoms and General Pathology

Rare Diseases

Ovarian Neoplasms

Carcinoma, Ovarian Epithelial

Anastomotic Leak

Endocrine Gland Neoplasms

Ovarian Diseases

Adnexal Diseases

Genital Diseases, Female

Genital Diseases

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Genital Neoplasms, Female

Urogenital Neoplasms

Endocrine System Diseases

Gonadal Disorders

Postoperative Complications

Ovarian Cancer

Ovarian Epithelial Cancer

C-reactive protein and PCT measured preoperatively, and on the second, fourth and sixth postoperative days.

Blood test

Antonio Gil-Moreno, MD

Asunción Pérez-Benavente, MD

José Luis Sánchez-Iglesias, MD

EDMOCS trial pretends to evaluate if C-reactive protein (CRP) and procalcitonin (PCT) can predict intestinal anastomotic leaks before early discharge in advanced ovarian cancer surgery requiring intestinal resection. These markers have already been positively tested in colorectal cancer surgery, but not yet in ovarian surgery.

Patients undergoing intestinal resection in ovarian cancer surgery will be included. C-reactive protein and PCT will be measured pre-operatively, and on the second, fourth and sixth postoperative day. Thirty-day readmissions, re-operations and mortality will be recorded.

Early Dehiscence Markers in Ovarian Cancer Surgery

Procalcitonin and C-Reactive Protein as Early Anastomotic Dehiscence Markers in Ovarian Cancer Surgery

To evaluate whether C-reactive protein (CRP) and procalcitonin (PCT) can predict anastomotic leak before early discharge.

Defining normal range values of C-Reactive Protein and Procalcitonin during postoperative ovarian cancer surgery.

Hospital Universitari Vall d'Hebron Research Institute

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Early Dehiscence Markers in Ovarian Cancer Surgery	NCT03131492	Ovarian Neoplas... Anastomotic Lea...	Blood test	18 Years -	Hospital Universitari Vall d'Hebron Research Institute
Early Dehiscence Markers in Ovarian Cancer Surgery	NCT03131492	Ovarian Neoplas... Anastomotic Lea...	Blood test	18 Years -	Hospital Universitari Vall d'Hebron Research Institute

Spots Global Cancer Trial Database for ovarian neoplasms malignant